PipelinePharma Logo

Generics 23

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Imatinib mesylate manufacturers

23 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

23 products found

imatinib mesylate

Tablets for oral solution 400 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Ref: Glivec (Novartis). In-house API
Manufacturer #19912

This global pharmaceutical company is a leading manufacturer of specialty formulations in oncology and anesthesia, with operations spanning the EU, North America, and other regions. They specialize in prescription medications, including lyophilized products, for key therapy areas such as cancer treatment and pain management. Their commitment to quality is reflected in their numerous GMP certifications, including WHO GMP, EU GMP, and TGA certifications. They prioritize innovation through research and development of new manufacturing processes and drug delivery mechanisms.

Manufacturer usually replies in 37 days

imatinib mesylate

Capsules 100 mg, 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20801

This CTD dossier owner and manufacturer specializes in producing a wide range of medications across various dosage forms, including tablets, capsules, injections, and syrups. Their focus is on delivering high-quality formulations for human health, evident in their commitment to using state-of-the-art technology and machinery. The company exports its products to several key regions globally, such as Africa, the CIS countries, Central and Latin America, Southeast Asia, and the Pacific. While they haven't specified particular therapy areas, their mission statement emphasizes a dedication to becoming a dominant player in both domestic and international markets. They prioritize maintaining the highest quality standards through rigorous quality control measures and emphasize safe, stable packaging for all products.

Manufacturer usually replies in 13 days

imatinib mesylate

Tablets 100 mg, 400 mg

Dossier type
ACTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
India
Manufacturer #18530
This pharmaceutical company specializes in a diverse range of products including prescription medications, over-the-counter drugs, medical devices, and supplements. They hold WHO-GMP certifications since 1965 and an ISO 9001:2015 certification, demonstrating their commitment to quality. Their expertise spans various therapy areas such as oncology/hormone therapies, cardiovascular health, and gastrointestinal conditions. They offer a wide range of dosage forms including capsules, tablets, syrups, and rectal suspensions. This company has a global presence, with products distributed across over 2000 countries. They are known for their contract manufacturing capabilities and new drug development expertise, holding over 300 ACTD dossiers.

Manufacturer usually replies in 13 days

Want to see all 23 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Imatinib Mesylate

Imatinib Mesylate is used to treat certain types of leukaemia, type of cancers that begins in the white blood cells, other cancers and disorders of the blood cells. Imatinib is also used to treat certain types of gastrointestinal stromal tumours, a type of tumour that grows in the walls of the digestive passages and may spread to other parts of the body. Imatinib is also used to treat tumours that forms under the top layer of skin, especially when the tumour cannot be removed surgically, has spread to other parts of the body, or has come back after surgery. Imatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.
Imatinib is sold under the brand name Gleevec among others.
Scientists at Ciba-Geigy (which merged with Sandoz in 1996 to become Novartis) invented Imatinib in the late 1990s, in a team led by biochemist Nicholas Lydon and that included Elisabeth Buchdunger and Jürg Zimmermann.

Forms and Dosage

It is sold in the tablet form in 100mg, 400mg strengths, in the treatment of Acute Lymphoblastic Leukaemia, the Indicated dosage for adults is 600 mg per day. In the treatment of Myelodysplastic/Myeloproliferative Diseases, the standard adult dose is 400 mg. in the treatment of Chronic Eosinophilic Leukemia, 100 mg which may increase to 400 mg. for treating Mastocytosis, the Indicated dosage for adults with aggressive systemic mastocytosis is 400 mg PO qDay and for Gastrointestinal Stromal Tumors, 400 mg

The cost of Imatinib Mesylate

The wholesale cost in the developing world is about US$1,386.49–19,162.50 a year. Whereas In the United States a typical dose for a year has a wholesale cost of $84,408, while in the United Kingdom the NHS was paying about £20,980 ($27,973) in 2016. Prices for a 100 mg pill of Gleevec internationally range from $20 to $30, although generic Imatinib is cheaper, as low as $2 per pill.

How does Imatinib Mesylatework?

Imatinib is a cancer growth blocker called a tyrosine kinase inhibitor. These inhibitors are proteins that cells use to signal to each other to grow. There are a number of different tyrosine kinases and blocking them stops the cancer cells growing. Imatinib targets different tyrosine kinases, depending on the type of cancer.

Finding Imatinib Manufacturers and Suppliers

The process of finding trusted Imatinib manufacturers and Imatinib suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities.
The robust search engine makes it convenient to search for manufacturers and suppliers of Imatinib . The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.